NCT06983327

Brief Summary

The goal of this study is to understand whether a brief, three session program can be helpful in reducing symptoms related to both chronic pain and stressful experiences/trauma.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable chronic-pain

Timeline
Completed

Started Apr 2025

Shorter than P25 for not_applicable chronic-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 14, 2025

Completed
Same day until next milestone

Study Start

First participant enrolled

April 14, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 21, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 28, 2025

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2025

Completed
Last Updated

March 10, 2026

Status Verified

February 1, 2026

Enrollment Period

8 months

First QC Date

April 14, 2025

Last Update Submit

March 9, 2026

Conditions

Outcome Measures

Primary Outcomes (5)

  • Feasibility of Recruitment

    Feasibility of recruitment: Rate of ≥70% of the patients who are identified as eligible for the study will agree to participate and enroll.

    At screening

  • Treatment Completion

    Rate of ≥70% of participants who start the intervention will complete at least 2 of the 3 sessions.

    From enrollment to end of treatment at 4 weeks

  • Feasibility of Data Collection

    Rate of ≥70% of participants will complete the survey at end of treatment and at 1-month follow-up.

    At end of treatment at (~4 weeks post-enrollment), and at 1-month follow-up (~8 weeks post-enrollment)

  • Treatment Credibility

    Rate of ≥70% of participants will report average credibility and expectancy scores greater than the scale's midpoint.

    At end of treatment at (~4 weeks post-enrollment), and at 1-month follow-up (~8 weeks post-enrollment)

  • Treatment Helpfulness

    Rate of ≥70% participants will report average treatment helpfulness scores greater than the scale's midpoint.

    At end of treatment at (~4 weeks post-enrollment), and at 1-month follow-up (~8 weeks post-enrollment)

Secondary Outcomes (4)

  • Pain Interference

    At end of treatment at (~4 weeks post-enrollment), and at 1-month follow-up (~8 weeks post-enrollment)

  • Pain Catastrophizing

    At end of treatment at (~4 weeks post-enrollment), and at 1-month follow-up (~8 weeks post-enrollment)

  • Posttraumtic Stress Disorder (PTSD) Symptoms

    At end of treatment at (~4 weeks post-enrollment), and at 1-month follow-up (~8 weeks post-enrollment)

  • Kinesiophobia

    At end of treatment at (~4 weeks post-enrollment), and at 1-month follow-up (~8 weeks post-enrollment)

Study Arms (1)

Brief Intervention

EXPERIMENTAL
Behavioral: Trauma Focused Emotional Awareness and Expression Therapy (EAET)

Interventions

The intervention is three-session program which includes pain neuroscience education, education on the relationship between trauma and chronic pain, and skills training to reduce pain- and stress-related symptoms.

Brief Intervention

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Presence of a chronic pain condition (pain for at least 3 months or more)
  • History of psychosocial trauma or stressful experience (Adverse Childhood Events questionnaire \[ACEs\] score of ≥ 3 OR Trauma History Questionnaire Score \[THQ\] of ≥ 2)
  • English fluency
  • Access to a smartphone, laptop, or computer
  • Able to participate in the intervention via a virtual platform

You may not qualify if:

  • Unable to participate in 3 weekly sessions
  • Unable to complete study procedures due to the presence of delirium, dementia, psychosis, or other cognitive impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brigham and Women's Hospital

Chestnut Hill, Massachusetts, 02467, United States

Location

MeSH Terms

Conditions

Chronic PainWounds and Injuries

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Psychologist

Study Record Dates

First Submitted

April 14, 2025

First Posted

May 21, 2025

Study Start

April 14, 2025

Primary Completion

November 28, 2025

Study Completion

November 30, 2025

Last Updated

March 10, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations